Waters Corp to Announce Strong Q1 Earnings on May 5th
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 04 2026
0mins
Should l Buy WAT?
Source: seekingalpha
Waters Corp's stock rose by 12.71% and reached a 5-day high amid positive earnings expectations.
The company is set to announce its Q1 2023 earnings on May 5th, with a consensus EPS estimate of $2.31, reflecting a 2.7% year-over-year growth. Additionally, revenue is projected to reach $1.2 billion, representing an impressive 81.3% year-over-year increase, which highlights the company's robust performance and may boost investor confidence. Waters has consistently beaten EPS and revenue estimates over the past two years, further enhancing market confidence in its future performance.
This upcoming earnings report is likely to attract significant investor interest, given the company's strong historical performance and optimistic revenue growth outlook.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WAT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WAT
Wall Street analysts forecast WAT stock price to rise
13 Analyst Rating
8 Buy
5 Hold
0 Sell
Moderate Buy
Current: 355.130
Low
350.00
Averages
414.08
High
480.00
Current: 355.130
Low
350.00
Averages
414.08
High
480.00
About WAT
Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Stocks Close Higher, Led by Tech Gains
- Tech Stock Surge: Intel's stock soared over 12% after Apple held exploratory talks with Intel and Samsung Electronics for U.S. processor production, indicating strong market confidence in tech stocks and driving gains across chipmakers.
- Oil Price Decline: WTI crude oil prices fell more than 3% as the ceasefire in the Middle East eased geopolitical risks, providing support for the stock market and reflecting market demand for stability amid fluctuating oil prices.
- New Home Sales Growth: U.S. March new home sales rose 7.4% month-over-month to 682,000, surpassing expectations of 652,000, indicating a robust recovery in the housing market that could bolster economic confidence.
- Positive Earnings Outlook: As of Tuesday, 83% of the 354 S&P 500 companies that reported Q1 earnings exceeded estimates, with projected earnings growth of 12% year-over-year, demonstrating sustained corporate profitability that may further drive stock market gains.
See More
China Emerges as a Leader in Global Pharmaceutical Innovation
- Earnings Beat: Waters reported adjusted earnings per share of $2.70, exceeding estimates of $2.31, with revenue of $1.27 billion surpassing the $1.20 billion forecast, indicating strong performance driven by the pharmaceutical segment, particularly in China.
- China's Market Growth: The pharmaceutical segment grew 14%, with China leading at over 50% growth, while India and Japan saw low-teens growth, highlighting China's rapid emergence as a key player in global pharmaceutical innovation and market expansion.
- Innovation-Driven Transformation: Despite a decline in China's generic drug market due to price restrictions, the development of innovative drugs is reshaping the landscape, with contract manufacturers rapidly scaling up to manage the entire process from discovery to development, aiming to create entities akin to Pfizer or AstraZeneca.
- Regional Performance: Asia's growth was nearly 30%, while the Americas and Europe achieved high single-digit growth, reflecting a diversified development trend in the global pharmaceutical market, with Waters' success underscoring the effectiveness of this strategic approach.
See More
Waters Corporation Reports Strong Q1 2026 Earnings and Raises Guidance
- Significant Earnings Growth: Waters Corporation reported a 20% increase in adjusted earnings per share to $2.70 for Q1 2026, reflecting strong performance post-merger, particularly with double-digit organic growth in legacy businesses, indicating sustained market demand.
- Margins Exceed Expectations: The total adjusted gross margin was 54.7%, approximately 200 basis points above expectations, while the adjusted operating margin reached 23.6%, also exceeding forecasts by 200 basis points, showcasing the company's success in cost control and operational efficiency.
- Guidance Raised: Management raised the full-year 2026 organic revenue growth guidance to 6.5%-8%, with total reported revenue expected to be approximately $6.405 billion to $6.455 billion, reflecting confidence in future performance, particularly from $15 million in expected revenue synergies from cross-selling.
- Integration Progress on Track: CEO Batra emphasized that the company is firmly on track to achieve its $55 million cost synergy target, with $50 million in expected revenue synergies this year, demonstrating effective execution and market adaptability in integrating newly acquired businesses.
See More
Rockwell Automation Surges on Strong Q2 Earnings Beat
- Strong Earnings Performance: Rockwell Automation reported a fiscal Q2 earnings per share of $3.30, exceeding analyst expectations of $2.88, with revenue of $2.24 billion surpassing the forecast of $2.16 billion, indicating robust market demand and operational efficiency.
- Upgraded Outlook: The company raised its fiscal 2026 profit outlook, reflecting confidence in future performance, which is likely to further boost investor sentiment and stock price.
- Competitor Struggles: Huntington Ingalls saw an 11% drop in shares despite free cash flow projections of $500 million to $600 million, falling short of the consensus estimate of $569.7 million, highlighting increasing competitive pressures in the industry.
- Positive Market Reaction: Other companies like DuPont and Waters Corp also saw stock price increases due to better-than-expected earnings, indicating a recovering market confidence in the manufacturing and technology sectors.
See More
US Stocks Rise, Nasdaq Hits All-Time High
- Nasdaq Milestone: The Nasdaq 100 index surged by 1.20%, reaching an all-time high, driven by robust performance in technology stocks, reflecting increased investor confidence in the tech sector's growth potential.
- Intel's Strong Surge: Intel's stock rose over 13%, leading chipmakers after Apple indicated exploratory discussions with Intel and Samsung to produce key processors in the US, which is expected to enhance Intel's market share and profitability.
- Economic Data Impact: March new home sales in the US rose by 7.4% month-over-month to 682,000 units, surpassing expectations and indicating signs of recovery in the housing market, while the April ISM services index fell slightly below expectations, highlighting the complexities of economic recovery that may influence future monetary policy.
- Crude Oil Price Drop: WTI crude oil prices fell by more than 4% as calm returned to the Middle East, easing geopolitical risks, which is expected to positively impact inflation expectations and provide support for the stock market.
See More
U.S. Stocks Rise, Nasdaq Hits All-Time High
- Nasdaq Milestone: The Nasdaq 100 index rose by 1.08%, reaching an all-time high, driven by strong performances in technology stocks, particularly Intel, which surged over 10%, indicating increased market confidence in the tech sector.
- Crude Oil Decline: WTI crude prices fell by more than 3% as calm returned to the Middle East, despite U.S. Central Command's announcement of military support for ships transiting the Strait of Hormuz, which could impact global energy supply dynamics.
- Widening Trade Deficit: The U.S. trade deficit widened to $60.3 billion in March from $57.8 billion in February, although it was narrower than the expected $61 billion, reflecting the complexities of economic recovery and its potential implications for the stock market.
- Strong Earnings Reports: So far, 82% of the 322 S&P 500 companies that reported Q1 earnings have exceeded estimates, with overall earnings projected to rise by 12% year-over-year, indicating improved corporate profitability that may further drive stock market gains.
See More
U.S. Stocks Close Higher, Led by Tech Gains
- Tech Stock Surge: Intel's stock soared over 12% after Apple held exploratory talks with Intel and Samsung Electronics for U.S. processor production, indicating strong market confidence in tech stocks and driving gains across chipmakers.
- Oil Price Decline: WTI crude oil prices fell more than 3% as the ceasefire in the Middle East eased geopolitical risks, providing support for the stock market and reflecting market demand for stability amid fluctuating oil prices.
- New Home Sales Growth: U.S. March new home sales rose 7.4% month-over-month to 682,000, surpassing expectations of 652,000, indicating a robust recovery in the housing market that could bolster economic confidence.
- Positive Earnings Outlook: As of Tuesday, 83% of the 354 S&P 500 companies that reported Q1 earnings exceeded estimates, with projected earnings growth of 12% year-over-year, demonstrating sustained corporate profitability that may further drive stock market gains.
See More
China Emerges as a Leader in Global Pharmaceutical Innovation
- Earnings Beat: Waters reported adjusted earnings per share of $2.70, exceeding estimates of $2.31, with revenue of $1.27 billion surpassing the $1.20 billion forecast, indicating strong performance driven by the pharmaceutical segment, particularly in China.
- China's Market Growth: The pharmaceutical segment grew 14%, with China leading at over 50% growth, while India and Japan saw low-teens growth, highlighting China's rapid emergence as a key player in global pharmaceutical innovation and market expansion.
- Innovation-Driven Transformation: Despite a decline in China's generic drug market due to price restrictions, the development of innovative drugs is reshaping the landscape, with contract manufacturers rapidly scaling up to manage the entire process from discovery to development, aiming to create entities akin to Pfizer or AstraZeneca.
- Regional Performance: Asia's growth was nearly 30%, while the Americas and Europe achieved high single-digit growth, reflecting a diversified development trend in the global pharmaceutical market, with Waters' success underscoring the effectiveness of this strategic approach.
See More
Waters Corporation Reports Strong Q1 2026 Earnings and Raises Guidance
- Significant Earnings Growth: Waters Corporation reported a 20% increase in adjusted earnings per share to $2.70 for Q1 2026, reflecting strong performance post-merger, particularly with double-digit organic growth in legacy businesses, indicating sustained market demand.
- Margins Exceed Expectations: The total adjusted gross margin was 54.7%, approximately 200 basis points above expectations, while the adjusted operating margin reached 23.6%, also exceeding forecasts by 200 basis points, showcasing the company's success in cost control and operational efficiency.
- Guidance Raised: Management raised the full-year 2026 organic revenue growth guidance to 6.5%-8%, with total reported revenue expected to be approximately $6.405 billion to $6.455 billion, reflecting confidence in future performance, particularly from $15 million in expected revenue synergies from cross-selling.
- Integration Progress on Track: CEO Batra emphasized that the company is firmly on track to achieve its $55 million cost synergy target, with $50 million in expected revenue synergies this year, demonstrating effective execution and market adaptability in integrating newly acquired businesses.
See More
Rockwell Automation Surges on Strong Q2 Earnings Beat
- Strong Earnings Performance: Rockwell Automation reported a fiscal Q2 earnings per share of $3.30, exceeding analyst expectations of $2.88, with revenue of $2.24 billion surpassing the forecast of $2.16 billion, indicating robust market demand and operational efficiency.
- Upgraded Outlook: The company raised its fiscal 2026 profit outlook, reflecting confidence in future performance, which is likely to further boost investor sentiment and stock price.
- Competitor Struggles: Huntington Ingalls saw an 11% drop in shares despite free cash flow projections of $500 million to $600 million, falling short of the consensus estimate of $569.7 million, highlighting increasing competitive pressures in the industry.
- Positive Market Reaction: Other companies like DuPont and Waters Corp also saw stock price increases due to better-than-expected earnings, indicating a recovering market confidence in the manufacturing and technology sectors.
See More
US Stocks Rise, Nasdaq Hits All-Time High
- Nasdaq Milestone: The Nasdaq 100 index surged by 1.20%, reaching an all-time high, driven by robust performance in technology stocks, reflecting increased investor confidence in the tech sector's growth potential.
- Intel's Strong Surge: Intel's stock rose over 13%, leading chipmakers after Apple indicated exploratory discussions with Intel and Samsung to produce key processors in the US, which is expected to enhance Intel's market share and profitability.
- Economic Data Impact: March new home sales in the US rose by 7.4% month-over-month to 682,000 units, surpassing expectations and indicating signs of recovery in the housing market, while the April ISM services index fell slightly below expectations, highlighting the complexities of economic recovery that may influence future monetary policy.
- Crude Oil Price Drop: WTI crude oil prices fell by more than 4% as calm returned to the Middle East, easing geopolitical risks, which is expected to positively impact inflation expectations and provide support for the stock market.
See More
U.S. Stocks Rise, Nasdaq Hits All-Time High
- Nasdaq Milestone: The Nasdaq 100 index rose by 1.08%, reaching an all-time high, driven by strong performances in technology stocks, particularly Intel, which surged over 10%, indicating increased market confidence in the tech sector.
- Crude Oil Decline: WTI crude prices fell by more than 3% as calm returned to the Middle East, despite U.S. Central Command's announcement of military support for ships transiting the Strait of Hormuz, which could impact global energy supply dynamics.
- Widening Trade Deficit: The U.S. trade deficit widened to $60.3 billion in March from $57.8 billion in February, although it was narrower than the expected $61 billion, reflecting the complexities of economic recovery and its potential implications for the stock market.
- Strong Earnings Reports: So far, 82% of the 322 S&P 500 companies that reported Q1 earnings have exceeded estimates, with overall earnings projected to rise by 12% year-over-year, indicating improved corporate profitability that may further drive stock market gains.
See More
